Study of Brexucabtagene Autoleucel Plus Dasatinib in Adults With Acute Lymphoblastic Leukemia

Condition:   Lymphoblastic Leukemia Intervention:   Drug: Dasatinib Sponsors:   Stanford University;   Kite Pharma Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials